BOBS
Next earnings: Aug 6, 2026
Signal
Leaning Bearish1
Price
1
Move+0.76%Quiet session
Volume
1
Volume1.1× avgNormal activity
Technical
1
TrendFull DowntrendBelow 50D & 200D
PRICE
Prev Close
11.82
Open
11.53
Day Range11.41 – 12.02
11.41
12.02
52W Range9.74 – 23.49
9.74
23.49
16% of range
VOLUME & SIZE
Avg Volume
1.2M
Float
130.6M
FUNDAMENTALS
P/E Ratio
14.0x
Value territory
EPS (TTM)
$0.85
Div Yield
No dividend
Performance
1D
+0.76%
5D
-4.34%
1M
+0.93%
3M
-40.69%
6M
-30.02%
YTD
-30.02%
1Y
-30.02%
Best: 1M (+0.93%)Worst: 3M (-40.69%)
Quick Read
Trend
DOWNTREND
Price below SMA50 & SMA200
Momentum
NEUTRAL
46% gross margin
Valuation
FAIR
P/E 14x vs ~20x sector
Health
WEAK
CR 0.9 (low) · FCF $0.74/sh
Bearish
Key MetricsTTM
Market Cap$1.56B
Revenue TTM
Net Income TTM
Free Cash Flow
Gross Margin45.7%
Net Margin5.1%
Operating Margin7.1%
Return on Equity38.8%
Return on Assets6.7%
Debt / Equity2.43
Current Ratio0.87
EPS TTM$1.10

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong1 watch3 concern
49/100
Liquidity
0.87Concern
Leverage
2.43Concern
Coverage
18.4xStrong
ROE
38.8%Strong
ROIC
9.8%Watch
Cash
$53MConcern
ANALYST COVERAGE7 analysts
BUY
+105.7%upside to target
L $14.00
Med $24.50consensus
H $26.00
Buy
686%
Hold
114%
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 7 signals bullish
3/10
Trend
Trend StateDowntrend (below both MAs)
Above SMA 50$12.47 (-4.5%)
Above SMA 200$14.57 (-18.2%)
Technicals
MA AlignmentDeath Cross (50D vs 200D -14.4%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.87 — liquidity risk
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
Technicals
Market Position
Price Levels
52W High
$23.49+97.2%
SMA 200
$14.57+22.3%
SMA 50
$12.47+4.7%
Current
$11.91
52W Low
$9.74-18.2%
52-Week RangeNear 52-week low
$9.7416th %ile$23.49
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 10 analysts
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$2.4B
$2.4B$2.4B
$0.96
±21%
High7
FY2026(current)
$2.6B
$2.6B$2.6B
+10.2%$0.93-3.6%
±2%
High10
FY2027
$2.8B
$2.8B$2.8B
+7.2%$1.06+13.9%
±3%
High10
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 4 consecutive quarters
Earnings HistoryBOBS
Last 4Q
+23.5%avg beat
Beat 4 of 4 quarters
+17%
Q1'26
+7%
Q1'26
+42%
Q2'26
+29%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d01
UBSBuy
Mar 2
DOWNGRADE
Insider Activity
SEC Filings →
2 Buys/0 SellsNet Buying
NET BUYERS$303K bought · $0 sold · 30d window
Barton William GDir
$300K
May 8
BUY
Barton William GDir
$2K
May 12
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
BAIN CAPITAL INVESTORS LLC
95.4M
2
FMR LLC
5.2M
3
Alyeska Investment Group, L.P.
2.5M
4
Sunriver Management LLC
1.5M
5
EMERALD ADVISERS, LLC
1.3M
6
BALYASNY ASSET MANAGEMENT L.P.
1.3M
7
CITADEL ADVISORS LLC
1.2M
8
Point72 Asset Management, L.P.
1.2M
News & Activity

BOBS News

About

No company information available